LifeMD (LFMDP) Latest Stock Analysis Report β Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $22.00, +0.00% vs the prior close of $22.00.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LFMDP ends flat (+0.0%) to $22.00. Closed at $22.00, +0.00% vs the prior close of $22.00. Day range $22.00β$22.00, opened at $22.00.
LFMDP daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 β LFMDP ends flat (+0.0%) to $22.00
- Closed at $22.00, +0.00% vs the prior close of $22.00. Day range $22.00β$22.00, opened at $22.00.
- Price is -4.8% vs its 50-day average ($23.11) and -5.1% vs its 200-day average ($23.19).
- 52-week range $18.50β$24.20; today's close sits at 61% of that range, 9.1% below the 52-week high.
Oct 14, 2026 β LFMDP dips 2.1% to $22.00, a 6-month low
- Closed at $22.00, -2.12% vs the prior close of $22.48. Day range $22.00β$22.44, opened at $22.44.
- Volume was 2.30K shares, 1.3x its 50-day average of 1.73K.
- Price is -4.9% vs its 50-day average ($23.14) and -5.1% vs its 200-day average ($23.18).
- 52-week range $18.50β$24.20; today's close sits at 61% of that range, 9.1% below the 52-week high.
Oct 13, 2026 β LFMDP rises 0.5% to $22.48
- Closed at $22.48, +0.49% vs the prior close of $22.37. Day range $22.44β$22.48, opened at $22.44.
- Volume was 600 shares, 0.3x its 50-day average of 1.76K β lighter than usual.
- Price is -3.0% vs its 50-day average ($23.17) and -3.0% vs its 200-day average ($23.18).
- 52-week range $18.50β$24.20; today's close sits at 70% of that range, 7.1% below the 52-week high.
Oct 12, 2026 β LFMDP ends flat (-0.0%) to $22.37
- Closed at $22.37, -0.04% vs the prior close of $22.38. Day range $22.30β$22.37, opened at $22.30.
- Volume was 700 shares, 0.4x its 50-day average of 1.77K β lighter than usual.
- Price is -3.5% vs its 50-day average ($23.19) and -3.5% vs its 200-day average ($23.17).
- 52-week range $18.50β$24.20; today's close sits at 68% of that range, 7.6% below the 52-week high.
Oct 9, 2026 β LFMDP ends flat (+0.1%) to $22.38
- Closed at $22.38, +0.09% vs the prior close of $22.36. Day range $22.38β$22.48, opened at $22.48.
- Volume was 400 shares, 0.2x its 50-day average of 1.78K β lighter than usual.
- Price is -3.6% vs its 50-day average ($23.21) and -3.4% vs its 200-day average ($23.17).
- 52-week range $18.50β$24.20; today's close sits at 68% of that range, 7.5% below the 52-week high.
Oct 8, 2026 β LFMDP ends flat (-0.2%) to $22.36, a 6-month low
- Closed at $22.36, -0.18% vs the prior close of $22.40. Day range $22.35β$22.40, opened at $22.35.
- Volume was 1.00K shares, 0.6x its 50-day average of 1.79K β lighter than usual.
- Price is -3.8% vs its 50-day average ($23.23) and -3.5% vs its 200-day average ($23.16).
- 52-week range $18.50β$24.20; today's close sits at 68% of that range, 7.6% below the 52-week high.
Oct 7, 2026 β LFMDP slides 4.1% to $22.40, a 6-month low
- Closed at $22.40, -4.07% vs the prior close of $23.35. Day range $21.97β$22.40, opened at $21.97.
- Volume was 1.80K shares, 1.0x its 50-day average of 1.79K.
- Price is -3.7% vs its 50-day average ($23.25) and -3.3% vs its 200-day average ($23.16).
- 52-week range $18.50β$24.20; today's close sits at 68% of that range, 7.4% below the 52-week high.
Oct 6, 2026 β LFMDP rises 2.1% to $23.35 on 3.8x normal volume
- Closed at $23.35, +2.14% vs the prior close of $22.86. Day range $20.97β$23.35, opened at $22.69.
- Volume was 6.30K shares, 3.8x its 50-day average of 1.67K β unusually heavy trading.
- Price is +0.3% vs its 50-day average ($23.28) and +0.9% vs its 200-day average ($23.15).
- 52-week range $18.50β$24.20; today's close sits at 85% of that range, 3.5% below the 52-week high.
Oct 5, 2026 β LFMDP rises 0.5% to $22.86
- Closed at $22.86, +0.53% vs the prior close of $22.74. Day range $22.80β$23.05, opened at $22.80.
- Volume was 900 shares, 0.5x its 50-day average of 1.66K β lighter than usual.
- Price is -1.8% vs its 50-day average ($23.28) and -1.2% vs its 200-day average ($23.13).
- 52-week range $18.50β$24.20; today's close sits at 76% of that range, 5.5% below the 52-week high.
Oct 2, 2026 β LFMDP dips 1.7% to $22.74, a 6-month low
- Closed at $22.74, -1.75% vs the prior close of $23.14. Day range $22.52β$22.75, opened at $22.75.
- Volume was 2.00K shares, 1.2x its 50-day average of 1.64K.
- Price is -2.4% vs its 50-day average ($23.29) and -1.7% vs its 200-day average ($23.13).
- 52-week range $18.50β$24.20; today's close sits at 74% of that range, 6.0% below the 52-week high.
LFMDP latest news & SEC filings
Every SEC filing by or about LFMDP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 25, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 15, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Aug 18, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 Β· Form 4/A β Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $47.28M (prior year $49.02M) (-3.5% vs Jun 30, 2025)
- Net income: -$7.08M (prior year -$1.62M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.16 (prior year -$0.05) (loss widened vs Jun 30, 2025)
Aug 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 8, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade LFMDP
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 9, 2026, Nov 17, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.72% (largest 4.1%). That is a relatively calm stock.
- Liquidity: about 1.61K shares (β$35.43K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $22.00 vs a range of $18.50β$24.20 (61% of the range).
- Dividends: last ex-dividend date Oct 2, 2026 ($0.555/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 1 sales; latest: Jessica Friedeman sold 15,000 shares on Dec 9, 2025.
- Latest filings: 8-K Sep 15, 2026; 10-Q Aug 5, 2026; 8-K Aug 5, 2026.
- Share count: 48.20M shares outstanding (Aug 4, 2026), +1.7% vs a year earlier.
- Listing: Nasdaq Β· industry: Services-Offices & Clinics of Doctors of Medicine.
LFMDP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 22.00 | 22.00 | 22.00 | 22.00 | 0 |
| Oct 14, 2026 | 22.44 | 22.44 | 22.00 | 22.00 | 2.30K |
| Oct 13, 2026 | 22.44 | 22.48 | 22.44 | 22.48 | 600 |
| Oct 12, 2026 | 22.30 | 22.37 | 22.30 | 22.37 | 700 |
| Oct 9, 2026 | 22.48 | 22.48 | 22.38 | 22.38 | 400 |
| Oct 8, 2026 | 22.35 | 22.40 | 22.35 | 22.36 | 1.00K |
| Oct 7, 2026 | 21.97 | 22.40 | 21.97 | 22.40 | 1.80K |
| Oct 6, 2026 | 22.69 | 23.35 | 20.97 | 23.35 | 6.30K |
| Oct 5, 2026 | 22.80 | 23.05 | 22.80 | 22.86 | 900 |
| Oct 2, 2026 | 22.75 | 22.75 | 22.52 | 22.74 | 2.00K |
| Oct 1, 2026 | 23.33 | 23.33 | 23.14 | 23.14 | 4.40K |
| Sep 30, 2026 | 23.06 | 23.06 | 23.06 | 23.06 | 0 |
| Sep 29, 2026 | 23.33 | 23.33 | 23.05 | 23.06 | 5.00K |
| Sep 28, 2026 | 23.15 | 23.15 | 23.15 | 23.15 | 0 |
| Sep 25, 2026 | 23.32 | 23.32 | 23.14 | 23.15 | 500 |
| Sep 24, 2026 | 23.20 | 23.20 | 23.20 | 23.20 | 1.00K |
| Sep 23, 2026 | 23.35 | 23.35 | 23.21 | 23.21 | 700 |
| Sep 22, 2026 | 23.10 | 23.35 | 23.09 | 23.35 | 2.90K |
| Sep 21, 2026 | 23.10 | 23.10 | 23.08 | 23.09 | 1.70K |
| Sep 18, 2026 | 23.14 | 23.14 | 23.14 | 23.14 | 0 |
About LifeMD
LifeMD (LFMDP) is listed on the Nasdaq and classified by the SEC under βServices-Offices & Clinics of Doctors of Medicineβ. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 948320.
LFMDP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Joseph Ditrolio | Director | Aug 13, 2026 |
| Joan Larovere | Director | Aug 18, 2026 |
| Calum Archibald Macrae | Director | Aug 13, 2026 |
| Roberto Simon | Director | Aug 13, 2026 |
| John R Jr Strawn | Director | Aug 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jessica Friedeman | Chief Marketing Officer | Dec 11, 2025 |
| Atul Kavthekar | Chief Financial Officer | May 13, 2026 |
| Christopher A Pisano | Chief Marketing Officer | Apr 1, 2026 |
| Umesh Sripad | Chief Technology Officer | Jun 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 9, 2025 | Jessica Friedeman | Sale | 15,000 | $3.61 |
LFMDP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $194.06M | $14.35M | 0.25 | $8.28M |
| Dec 31, 2024 | $154.82M | $-21.41M | -0.60 | $17.51M |
| Dec 31, 2023 | $152.55M | $-20.60M | β | $8.82M |
| Dec 31, 2022 | $119.03M | $-45.54M | β | $-22.94M |
| Dec 31, 2021 | $92.88M | $-60.90M | β | $-33.09M |
Latest balance sheet: total assets $59.89M, total liabilities $51.93M, cash $36.23M (as of Jun 30, 2026).
LFMDP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $23.50 |
| May 6, 2026 | 8-K Item 2.02 (results) | $23.83 |
| Mar 9, 2026 | 8-K Item 2.02 (results) | $22.57 |
| Nov 17, 2025 | 8-K Item 2.02 (results) | $23.84 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $24.03 |
| May 6, 2025 | 8-K Item 2.02 (results) | $24.15 |
| Mar 10, 2025 | 8-K Item 2.02 (results) | $21.91 |
| Jan 19, 2022 | 8-K Item 2.02 (results) | β |
| May 13, 2021 | 8-K Item 2.02 (results) | β |
| Apr 19, 2021 | 8-K Item 2.02 (results) | β |
| Apr 1, 2021 | 8-K Item 2.02 (results) | β |
| Jan 19, 2021 | 8-K Item 2.02 (results) | β |
Related stocks Β· Services-Offices & Clinics of Doctors of Medicine
Hims & Hers Health (HIMS)Teladoc Health (TDOC)Starling Oncology (STLN)Basel Medical (BMGL)LifeMD (LFMD)Auna (AUNA)SBC Medical (SBC)Airsculpt Technologies (AIRS)Concord Medical Services (CCM)Westin Acquisition (WSTN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on LFMDP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.